At Alex Therapeutics, we develop CE-certified Digital Therapeutics (DTx) products.
We are a pioneer within our field, combining Cognitive Behavioural Therapy (CBT) and Acceptance and Commitment Therapy (ACT) with Artifical Intelligence to provide our patients with highly personalized and effective care.
Our first product, Alex AI - Quit Smoking, combines CBT with AI to help patients treat Nicotine Addiction. So far over 100,000 patients have chosen Alex AI to help them overcome their Nicotine Addiction.
The Alex Platform allows for the easy development of new products and we see incredible potential in future verticals such as obesity, depression, oncology and more.
We’re always looking for great new partners and co-workers. Send us an email at hello@alextherapeutics.com to get in touch.
Location: Sweden, Stockholm
Employees: 11-50
Total raised: $3.82M
Founded date: 2018
Investors 1
Date | Name | Website |
19.04.2022 | Hadean Ven... | hadeanvent... |
Funding Rounds 1
Date | Series | Amount | Investors |
06.04.2022 | - | $3.82M | - |
Mentions in press and media 15
Date | Title | Description | Source |
04.01.2024 | Alex Therapeutics Reports Positive Results from the Randomiz... | Alex Therapeutics Reports Positive Results from the Randomized-Controlled Trial of its Digital Thera... | news.cisio... |
05.03.2023 | Alex Therapeutics extends financing round to €4.75M with lea... | Innovestor Life Science, a leading biotech and digital health VC, invests €1.25M in the digital ther... | hadeanvent... |
13.10.2022 | Alex Therapeutics presents results from digital therapeutic ... | The Digital Therapeutic (DTx) was developed by DTx leader Alex Therapeutics using the proprietary &q... | en.prnasia... |
21.04.2022 | Vicore launches COMPANION, a clinical study investigating th... | Vicore launches COMPANION, a clinical study investigating the benefit of digital therapy on anxiety ... | news.cisio... |
21.04.2022 | Clinical study investigating Alex Therapeutics’ and Vicore’s... | Clinical study investigating Alex Therapeutics’ and Vicore’s standalone digital therapy (DTx) treati... | news.cisio... |
06.04.2022 | Alex Therapeutics raises €3.5M in oversubscribed financing r... | Alex Therapeutics raises €3.5M in oversubscribed financing round from top tier VC investors to advan... | news.cisio... |
06.04.2022 | Alex Therapeutics raises €3.5M in oversubscribed financing r... | STOCKHOLM, April 6, 2022 /PRNewswire/ -- Stockholm-based Digital Therapeutics (DTx) company Alex The... | en.prnasia... |
06.04.2022 | Alex Therapeutics raises €3.5M in oversubscribed financing r... | STOCKHOLM, April 6, 2022 /PRNewswire/ — Stockholm-based Digital Therapeutics (DTx) company Alex Th... | hadeanvent... |
06.04.2022 | DTx startup Alex Therapeutics scores €3.5M | Photo: Thomas M. Barwick/Getty Images Stockholm-based digital therapeutics startup Alex Therapeutic... | mobihealth... |
31.01.2022 | Pfizer and Alex Therapeutics announce a Strategic Commercial... | The Stockholm-based Digital Therapeutics (DTx) company Alex Therapeutics and world leading pharmaceu... | marketscre... |
Show more